1. Home
  2. RCKT vs RNGR Comparison

RCKT vs RNGR Comparison

Compare RCKT & RNGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RCKT
  • RNGR
  • Stock Information
  • Founded
  • RCKT 1999
  • RNGR 2017
  • Country
  • RCKT United States
  • RNGR United States
  • Employees
  • RCKT N/A
  • RNGR N/A
  • Industry
  • RCKT Biotechnology: Pharmaceutical Preparations
  • RNGR Oilfield Services/Equipment
  • Sector
  • RCKT Health Care
  • RNGR Energy
  • Exchange
  • RCKT Nasdaq
  • RNGR Nasdaq
  • Market Cap
  • RCKT 328.6M
  • RNGR 279.8M
  • IPO Year
  • RCKT N/A
  • RNGR 2017
  • Fundamental
  • Price
  • RCKT $3.05
  • RNGR $12.58
  • Analyst Decision
  • RCKT Buy
  • RNGR Hold
  • Analyst Count
  • RCKT 13
  • RNGR 1
  • Target Price
  • RCKT $12.88
  • RNGR $15.00
  • AVG Volume (30 Days)
  • RCKT 2.6M
  • RNGR 164.5K
  • Earning Date
  • RCKT 08-07-2025
  • RNGR 07-28-2025
  • Dividend Yield
  • RCKT N/A
  • RNGR 1.91%
  • EPS Growth
  • RCKT N/A
  • RNGR 53.19
  • EPS
  • RCKT N/A
  • RNGR 0.99
  • Revenue
  • RCKT N/A
  • RNGR $571,900,000.00
  • Revenue This Year
  • RCKT N/A
  • RNGR N/A
  • Revenue Next Year
  • RCKT $591.46
  • RNGR $1.45
  • P/E Ratio
  • RCKT N/A
  • RNGR $12.76
  • Revenue Growth
  • RCKT N/A
  • RNGR N/A
  • 52 Week Low
  • RCKT $2.19
  • RNGR $10.56
  • 52 Week High
  • RCKT $22.01
  • RNGR $18.45
  • Technical
  • Relative Strength Index (RSI)
  • RCKT 49.19
  • RNGR 49.25
  • Support Level
  • RCKT $2.83
  • RNGR $12.46
  • Resistance Level
  • RCKT $3.22
  • RNGR $13.14
  • Average True Range (ATR)
  • RCKT 0.17
  • RNGR 0.55
  • MACD
  • RCKT 0.01
  • RNGR -0.05
  • Stochastic Oscillator
  • RCKT 41.51
  • RNGR 7.69

About RCKT Rocket Pharmaceuticals Inc.

Rocket Pharmaceuticals Inc is a late-stage biopharmaceutical company. It is focused on the development of gene therapies for rare and devastating pediatric diseases. The pipeline products of the company include RP-A501 for Danaon Disease, RP-L102 for Fanconi Anemia, RP-L201 for Leukocyte Adhesion, RP-L301 for Pyruvate Kinase Deficiency, and RP-L401 for Infantile Malignant Osteopetrosis. The Company has one reportable segment related to R&D and commercial readiness of its gene therapies.

About RNGR Ranger Energy Services Inc.

Ranger Energy Services Inc is a provider of onshore high-specification (high-spec) well service rigs, wireline services, and additional processing solutions and ancillary services in the United States. It offers a range of well-site services to U.S. exploration and production (E&P) companies that are fundamental to establishing and enhancing the flow of oil and natural gas throughout the productive life of a well. The segments of the group are High Specification Rigs, Wireline Services and Processing Solutions, and Ancillary Services, of which key revenue is derived from the High Specification Rigs segment.

Share on Social Networks: